Australian Personalised mRNA Cancer Immunotherapy Hub Head associate professor Seth Cheetham joined Ross Stevenson and Russel Howcroft to discuss an experimental melanoma drug that delivers treatment tailored to a patient's specific tumour which has prevented the deadly form of skin cancer from returning in a large clinical trial by US pharmaceutical giants Merck and Moderna.